Algert Global LLC Akero Therapeutics, Inc. Transaction History
Algert Global LLC
- $3.01 Billion
- Q2 2024
A detailed history of Algert Global LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Algert Global LLC holds 62,861 shares of AKRO stock, worth $1.81 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
62,861
Previous 87,423
28.1%
Holding current value
$1.81 Million
Previous $2.21 Million
33.2%
% of portfolio
0.05%
Previous 0.09%
Shares
6 transactions
Others Institutions Holding AKRO
# of Institutions
168Shares Held
72.7MCall Options Held
178KPut Options Held
164K-
Janus Henderson Group PLC London, X06.88MShares$198 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$161 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.43MShares$157 Million2.13% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$151 Million3.88% of portfolio
-
Wellington Management Group LLP Boston, MA5.11MShares$147 Million0.02% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $1.34B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...